Fracture risk of women with primary biliary cirrhosis: No increase compared with general population controls

Alimentary Pharmacology and Therapeutics

Volumn 20, Issue 5, 2004, Pages 551-557

  Boulton Jones, J R ^a   Fenn, R M F ^a   West, J ^a   Logan, R F A ^a   Ryder, S D ^a,b  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; BONE DENSITY; BONE MINERAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FRAGILITY FRACTURE; HUMAN; LONG BONE; POSTMENOPAUSE OSTEOPOROSIS; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; RISK FACTOR;

ADULT; AGED; CASE-CONTROL STUDIES; COHORT STUDIES; ENGLAND; FEMALE; FRACTURES, BONE; HUMANS; LIVER CIRRHOSIS, BILIARY; MIDDLE AGED; ODDS RATIO; OSTEOPOROSIS; RISK FACTORS;

EID: 4544316947     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2004.02089.x     Document Type: Article

References (23)

1. Guanabens N, Pares A, Marinoso L, et al. Factors influencing the development of metabolic bone disease in primary biliary cirrhosis. Am J Gastroenterol 1990; 85: 1356-62.
2. Springer JE, Cole DEC, Rubin LA, et al. Vitamin D-receptor genotypes as independent genetic predictors of decreased bone mineral density in primary biliary cirrhosis. Gastroenterology 2000; 118: 145-51.
3. Hodgson SF, Dickson ER, Wahner HW, Johnson KA, Mann KG. Bone loss and reduced osteoblast function in primary biliary cirrhosis. Ann Intern Med 1985; 103: 855-60.
4. Lindor KD, Janes CH, Crippen JS, Jorgenson R, Dickson ER. Bone disease in primary biliary cirrhosis: does ursodeoxycholic acid make a difference? Hepatology 1995; 21: 389-92.
5. Periera SP, Bray GP, Pitt PI, Li F, Moniz C, Williams R. Non-invasive assessment of bone mineral density in primary biliary cirrhosis. Eur J Gastroenterol Hepatol 1999; 11: 323-8.
6. Crippen S, Jorgensen RA, Dickson ER, Lindor KD. Hepatic osteodystrophy in primary biliary cirrhosis: effects of medical treatment. Am J Gastroenterol 1994; 89: 47-50.
7. Eastell R, Dickson ER, Hodgson SF, et al. Rates of vertebral bone loss before and after liver transplantation in patients with primary biliary cirrhosis. Hepatology 1991; 14: 296-300.
8. Pares A, Guanabens N, Alvarez L, et al. Collagen type I alpha 1 and vitamin D receptor gene polymorphisms and bone mass in primary biliary cirrhosis. Hepatology 2001; 33: 554-60.
9. Mitchison HC, Malcolm AJ, Bassedine MF, James OFW. Metabolic bone disease in osteoporosis at presentation. Gastroenterology 1988; 94: 463-70.
10. Van Berkum FNR, Beukers R, Birkenhager JC, Kooig PPM, Schalm SW, Pols HAP. Bone mass in women with primary biliary cirrhosis: the relationship with histological stage and use of glucocorticoids. Gastroenterology 1990; 99: 1134-9.
11. Newton J, Francis R, Prince M, et al. Osteoporosis in primary biliary cirrhosis revisited. Gut 2001; 49: 282-7.
12. Shih MS, Anderson C. Does hepatic osteodystrophy differ from peri- and postmenopausal osteoporosis: a histomorphometric study. Calcif Tissue Int 1987; 41: 187-91.
13. Stellon AJ, Davies A, Compston J, Williams R. Osteoporosis in chronic cholestatic liver disease. Q J Med 1985; 57: 783-90.
14. Lindor KD, Jorgensen RA, Tiegs RD, et al. Etidronate for osteoporosis in primary biliary cirrhosis: a randomised trial. J Hepatol 2000; 33: 878-82.
15. Howel D, Fischbacher CM, Bhopal RS, Gray J, Metclf JV, James OFW. An exploratory population-based case-control study of primary biliary cirrhosis. Hepatology 2000; 31: 1055-60.
16. Ward KD, Klesges RC. A meta-analysis of the effects of cigarette smoking on bone mineral density. Calcif Tissue Int 2001; 68: 259-70.
17. Vestergaaed P, Krogh K, Rejmark L, Khosla S, Dickson ER. Fracture risk is increased in Crohn's disease, but not in ulcerative colitis. Gut 2000; 46: 176-81.
18. van Staa TP, Dennison EM, Leufkens HG, Cooper E. Epidemiology of fractures in England and Wales. Bone 2001; 29: 517-22.
19. Cummings SR, Melton LJI. Epidemiology and outcome of osteoporotic fractures. Lancet 2002; 350: 1761-7.
20. Guanabens N, Pares A, Monegal A, Peris P, Pons F, Alvarez L. Etidronate versus fluoride for the treatment of osteopenia in primary biliary cirrhosis: preliminary results after 2 years. Gastroenterology 1997; 112: 219-24.
21. Floreani A, Chiaramonte M, Giannini S, et al. Longitudinal study on osteodystrophy in primary biliary cirrhosis (PBC) and a pilot study of calcitonin treatment. J Hepatol 1991; 12: 217-23.
22. Shiomi S, Masaki K, Habu D, et al. Calcitriol for bone loss in patients with primary biliary cirrhosis. J Gastroenterol 1999; 34: 241-5.
23. Collier JD, Ninkoic M, Compston JE. Guidelines for the management of osteoporosis associated with chronic liver disease. Gut 2002; 50(Suppl. 1): i1-i9.